| # | Drug | Count |
|---|---|---|
| 0 | OSIMERTINIB | 47 |
| 1 | VALGANCICLOVIR | 20 |
| 2 | VALGANCICLOVIR HYDROCHLORIDE | 20 |
| 3 | IMATINIB | 19 |
| 4 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 17 |
| 5 | GANCICLOVIR SODIUM | 14 |
| 6 | TACROLIMUS | 14 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 |
| 8 | TACROLIMUS OINTMENT 0.1% | 14 |
| 9 | GANCICLOVIR | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TECOVIRIMAT MONOHYDRATE | 1 | 0.0096 |
| 1 | DORAVIRINE | 5 | 0.0063 |
| 2 | MARIBAVIR | 7 | 0.0028 |
| 3 | LAROTRECTINIB | 2 | 0.0022 |
| 4 | FOSCARNET SODIUM | 7 | 0.0017 |
| 5 | QUIZARTINIB | 1 | 0.0014 |
| 6 | GANCICLOVIR SODIUM | 14 | 0.0013 |
| 7 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 8 | LETERMOVIR | 4 | 0.0012 |
| 9 | AFATINIB | 8 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 1 | 0.0096 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 7 | 0.0028 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 21 | 0.0009 |
| 4 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 5 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 7 | 0.0005 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0004 |